The webinar also touched upon how pharmacies can leverage the latest AI advancements in medical billing, streamline workflows ...
Improving access to care and boosting patient and provider experience via digital — with and without AI — were among the main talking points at this ...
Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its rivalry ...
From finding innovative ways to strengthen the workforce and gaining insights on how to navigate change and adversity to leveraging artificial intelligence to enhance clinical workflows, the upcoming ...
The FDA has started a review of Bristol-Myers Squibb's immunotherapy duo Opdivo and Yervoy as a therapy for newly diagnosed unresectable liver cancer that could see a return to the category for the ...
After starting my career at PCMag as an intern more than a decade ago, I’m back as one of its editors, focused on managing laptops, desktops, and components coverage. With 15 years of experience, I ...
Stay informed on developments in cancer and oncology diagnosis, prevention and treatment through these curated webinars. As the race toward a cure for cancer continues, advances in cancer research are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results